^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    DNADX®

    Company:
    Reveal Genomics
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    DNADX is a groundbreaking test designed for patients facing advanced breast cancer. Its proprietary software, used for diagnostic testing, examines the DNA from tumor tissue or circulating tumor DNA (ctDNA) in the blood. By analyzing distinctive gene patterns, crucial details that go beyond single gene alterations, offer valuable insights to shape personalized and targeted treatment plans.
    Cancer:
    Breast Cancer
    Method:
    Circulating tumor DNA (ctDNA)